Sirona Biochem Corp. Stock Other OTC
Equities
SRBCF
CA82967M1005
Biotechnology & Medical Research
Sales 2022 | 672K 488K | Sales 2023 | 34.78K 25.25K | Capitalization | 21.44M 15.56M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.18M | Net income 2023 | -2M -1.45M | EV / Sales 2022 | 48.8 x |
Net Debt 2022 | 48.04K 34.87K | Net Debt 2023 | 1.61M 1.17M | EV / Sales 2023 | 663 x |
P/E ratio 2022 |
-8.81
x | P/E ratio 2023 |
-8.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.41% |
Managers | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 06-10-18 |
Director of Finance/CFO | - | 09-04-28 | |
Chief Tech/Sci/R&D Officer | - | 11-03-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 06-10-18 |
Alex Marazzi
BRD | Director/Board Member | - | 06-10-18 |
Director of Finance/CFO | - | 09-04-28 |
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |